Clinical Coagulation, Malmö

341 – 350 of 659

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/v1000575?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
34
35
36
37
…
66
next »

2013
Mark Pharmacokinetics of plasma-derived and recombinant factor IX: using population pharmacokinetics with sparse sampling data needs further study.
Berntorp, Erik ^LU (2013) In Haemophilia 19(6). p.805-807
- Contribution to journal › Debate/Note/Editorial
Mark Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden.
Lövdahl, Susanna ^LU ; Henriksson, Marie ^LU ; Baghaei, F ; Holmström, Eva M ^LU ; Nilsson, J-Å ; Berntorp, Erik ^LU and Astermark, Jan ^LU (2013) In Haemophilia 19(3). p.362-369
- Contribution to journal › Article
Mark Platelet count kinetics following Interruption of antiretroviral treatment: Results from the SMART study.
Zetterberg, Eva ^LU ; Neuhaus, Jacqueline ; Baker, Jason V ; Somboonwit, Charurut ; Llibre, Josep M ; Palfreeman, Adrian ; Chini, Maria and Lundgren, Jens D (2013) In AIDS 27(1). p.59-68
- Contribution to journal › Article
Mark Socioeconomic factors and concomitant diseases are related to the risk for venous thromboembolism during long time follow-up.
Isma, Nazim ^LU ; Merlo, Juan ^LU ; Ohlsson, Henrik ^LU ; Svensson, Peter ^LU ; Lindblad, Bengt ^LU and Gottsäter, Anders ^LU (2013) In Journal of Thrombosis and Thrombolysis 36(1). p.58-64
- Contribution to journal › Article
Mark Prasugrel 5-mg in the very elderly attenuates platelet inhibition but maintains non-inferiority to prasugrel 10-mg in non-elderly patients: The GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients.
Erlinge, David ^LU ; Gurbel, Paul A ; James, Stefan ; Lindahl, Tomas L ; Svensson, Peter ^LU ; Ten Berg, Jurrien M ; Foley, David P ; Wagner, Henrik ^LU ; Brown, Patricia B and Luo, Junxiang , et al. (2013) In Journal of the American College of Cardiology 62(7). p.577-583
- Contribution to journal › Article
Mark Dabigatran in clinical practice - One-year experience at Skåne University Hospital.
Bergman, Elin ; Smith, Gustav ^LU ; Wieloch, Mattias ^LU ; Braun, Oscar ^LU ; Svensson, Peter ^LU and vanderPals, Jesper ^LU (2013) In Thrombosis Research 132(2). p.316-317
- Contribution to journal › Letter
Mark F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
Schwarz, J. ; Astermark, Jan ^LU ; Menius, E. D. ; Carrington, M. ; Donfield, S. M. ; Gomperts, E. D. ; Nelson, G. W. ; Oldenburg, J. ; Pavlova, A. and Shapiro, A. D. , et al. (2013) In Haemophilia 19(1). p.113-118
- Contribution to journal › Article
Mark Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.
Saemundsson, Ymir ; Sveinsdottir, Signý Vala ; Svantesson, Henrik and Svensson, Peter ^LU (2013) In Journal of Thrombosis and Thrombolysis 36(3). p.324-331
- Contribution to journal › Article
Mark Intermediate- dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
Fischer, Kathelijn ; Steen Carlsson, Katarina ^LU ; Petrini, Pia ; Holmstrom, Margareta ; Ljung, Rolf ^LU ; van den Berg, H. Marijke and Berntorp, Erik ^LU (2013) In Blood 122(7). p.1129-1136
- Contribution to journal › Article
Mark Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study
Gringeri, A. ; Leissinger, C. ; Cortesi, P. A. ; Jo, H. ; Fusco, F. ; Riva, S. ; Antmen, B. ; Berntorp, Erik ^LU ; Biasoli, C. and Carpenter, S. , et al. (2013) In Haemophilia 19(5). p.736-743
- Contribution to journal › Article

« previous
1
…
34
35
36
37
…
66
next »